Effector Therapeutics Inc (EFTR) Directors and Executive Officers - CSIMarket
CSIMarket
 
Effector Therapeutics Inc   (NASDAQ: EFTR)

Effector Therapeutics Inc

Officers & Directors


Stephen Worland, Ph.D.
President and Chief Executive Officer - (Principal Executive Officer)

Barbara Klencke
Director

Elizabeth P. Bhatt
Director

Kristen Harrington-Smith
Director

Caroline Loewy
Director

Brian M. Gallagher, Jr., Ph.D.
Director and Board Chair

Michael Byrnes
Chief Financial Officer - (Principal Financial and Accounting Officer)

Chris Ehrlich
Director ,

Effector Therapeutics Inc currently has 47 employees.

  News about Effector Therapeutics Inc Key Personnel

eFFECTOR Therapeutics Faces Delisting and Wind Down amidst Financial Struggles

eFFECTOR Therapeutics Announces Wind Down and Delisting from Nasdaq
eFFECTOR Therapeutics, a biotechnology company based in Solana Beach, California, has made the decision to terminate its employees and wind down its operations. The company also plans to explore potential strategic alternatives for its development programs. This significant move was decided upon during a special meeting of the board of directors.
In addition to these plans, eFFECTOR Therapeutics has disclosed that its securities currently do not meet the continued listing requirements of the Nasdaq Stock Market. As a result, the company s securities are expected to be delisted if compliance with the requirements is not regained with...






EFTR Management Effectiveness EFTR Revenue per Employee EFTR Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.